Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Kant

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Nephrology|August 1, 1990
Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrodS Hariharan, V E Pollak, K S Kant, et al.
Clinical and Experimental Immunology|October 1, 1977
Lymphocytotoxins in epileptic patients receiving phenytoinB S Ooi, K S Kant, I B Hanenson, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritisP Glas-Greenwalt, K S Kant, A Dosekun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1992
Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysisK S Kant, H I Glueck, M C Coots, et al.
Medicine|January 1, 1994
Pancreatitis in patients with end-stage renal diseaseB Padilla, V E Pollak, A Pesce, et al.
Archives of Internal Medicine|August 1, 1985
Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulantsH I Glueck, K S Kant, M A Weiss, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrodK S Kant, V E Pollak, A Dosekun, et al.
Clinical Nephrology|October 1, 1985
Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin)X H Du, P Glas-Greenwalt, K S Kant, et al.
Thrombosis Research|September 15, 1982
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observationsK S Kant, A K Dosekun, K G Chandran, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Nephrology|August 1, 1990
Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrodS Hariharan, V E Pollak, K S Kant, et al.
Clinical and Experimental Immunology|October 1, 1977
Lymphocytotoxins in epileptic patients receiving phenytoinB S Ooi, K S Kant, I B Hanenson, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritisP Glas-Greenwalt, K S Kant, A Dosekun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1992
Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysisK S Kant, H I Glueck, M C Coots, et al.
Medicine|January 1, 1994
Pancreatitis in patients with end-stage renal diseaseB Padilla, V E Pollak, A Pesce, et al.
Archives of Internal Medicine|August 1, 1985
Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulantsH I Glueck, K S Kant, M A Weiss, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrodK S Kant, V E Pollak, A Dosekun, et al.
Clinical Nephrology|October 1, 1985
Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin)X H Du, P Glas-Greenwalt, K S Kant, et al.
Thrombosis Research|September 15, 1982
Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observationsK S Kant, A K Dosekun, K G Chandran, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Pageof 3